| UHC UMR Medical and Drug | Bariatric Surgery - Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Breast Imaging for Screening and Diagnosing Cancer - Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Cimzia® (Certolizumab Pegol) - Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Computer-Assisted Surgical Navigation for Musculoskeletal Procedures - Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Cytological Examination of Breast Fluids for Cancer Screening or Diagnosis - Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Deep Brain and Cortical Stimulation - Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Infliximab (Avsola®, Inflectra®, Remicade®, & Renflexis®) - Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Inhaled Nitric Oxide Therapy - Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Intravenous Iron Replacement Therapy (Feraheme®, Injectafer®, & Monoferric®) - Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Kisunla(TM) (Donanemab-Azbt) - Commercial Medical Benefit Drug Policy | 2026-02-01 |